Clincosm LogoSign in Get a demo

CLEAR Stress: Longitudinal Survey Analysis in Lymphoma Survivors

Sponsor
Weill Medical College of Cornell University (Other)
Overall Status
Completed
CT.gov ID
NCT01469754
Collaborator
(none)
97
Enrollment
1
Location
24
Duration (Months)
4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Posttraumatic Stress Disorder (PTSD) is a well-documented phenomenon that occurs in cancer survivors. PTSD is known to cause problems with anxiety, depression, and quality of life. Furthermore, there is little treatment available for cancer survivors who suffer from PTSD.

Posttraumatic Growth, however, is a lesser known phenomenon that also occurs in cancer survivors. It is a positive psychological phenomenon that occurs in some people who have suffered a traumatic event--the people who are able to note a "greater appreciation for life", a "stronger relationship with their family/friends," or a "new found level of spirituality" are examples of instances of posttraumatic growth.

Coping with Lymphoma to Enhance Adjustment and Reduce Stress in Survivors (CLEAR Stress) is a study designed to compare the development of PTSD versus the development of Posttraumatic Growth in lymphoma patients at any stage of the cancer experience, regardless of treatment. The hypothesis is that posttraumatic growth, if it is significant, can reduce the impact of PTSD symptoms in the survivor.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    97 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Coping With Lymphoma to Enhance Adjustment and Reduce Stress in Lymphoma Survivors
    Study Start Date :
    Sep 1, 2011
    Actual Primary Completion Date :
    Jul 1, 2013
    Actual Study Completion Date :
    Sep 1, 2013

    Arms and Interventions

    Arm Intervention/Treatment
    Lymphoma Survivors

    Outcome Measures

    Primary Outcome Measures

    1. Posttraumatic Growth [Measured at enrollment]

    Secondary Outcome Measures

    1. Posttraumatic Stress Disorder (PTSD) [Measured at Enrollment]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    • Diagnosis of Lymphoma (includes Waldenstrom's Macroglobulinemia)

    • Can read/write/understand English without a translator

    Exclusion Criteria:

    • Currently Hospitalized

    • Active Psychosis

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 New York Presbyterian/Weill Cornell Center for Lymphoma and Myeloma New York New York United States 10065

    Sponsors and Collaborators

    • Weill Medical College of Cornell University

    Investigators

    • Principal Investigator: Regina A Jacob, MD, WCMC Research Fellow

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Weill Medical College of Cornell University
    ClinicalTrials.gov Identifier:
    NCT01469754
    Other Study ID Numbers:
    • 1107011786
    First Posted:
    Nov 10, 2011
    Last Update Posted:
    May 5, 2014
    Last Verified:
    May 1, 2014
    Keywords provided by Weill Medical College of Cornell University
    lymphoma
    survivors
    posttraumatic growth
    posttraumatic stress
    longitudinal
    Additional relevant MeSH terms:
    Lymphoma
    Stress Disorders, Post-Traumatic

    Study Results

    No Results Posted as of May 5, 2014